|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 19.90 EUR | -5.24% |
|
-2.45% | -28.93% |
| 1 day | -5.24% | ||
| 1 week | -2.45% | ||
| Current month | -11.16% | ||
| 1 month | -11.16% | ||
| 3 months | -7.01% | ||
| 6 months | -28.42% | ||
| Current year | -28.93% |
| 1 week | 19.8 |  | 21 |
| 1 month | 19.8 | | 23.8 |
| Current year | 19.8 | | 28 |
| 1 year | 15 | | 31.4 |
| 3 years | 7.5 | | 32.6 |
| 5 years | 5 | | 32.6 |
| 10 years | 5 | | 32.6 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Corporate Officer/Principal | 52 | 2014-12-31 | |
Liina Kervemann
DFI | Director of Finance/CFO | - | - |
Erik Berlin
PRN | Corporate Officer/Principal | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Karita Sall
BRD | Director/Board Member | 52 | - |
Yoann John Ricau
BRD | Director/Board Member | 51 | - |
Martin Wilson
BRD | Director/Board Member | 49 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -5.24% | -2.45% | -17.08% | +151.26% | 38.32M | |
| -0.66% | -0.29% | +11.15% | +77.11% | 47.58B | |
| -0.96% | +0.89% | +51.10% | +104.99% | 35.47B | |
| +0.78% | +2.25% | -2.69% | +44.38% | 12.42B | |
| -0.78% | +0.04% | +12.39% | +90.82% | 11.83B | |
| +2.46% | -2.31% | +32.29% | +118.03% | 8.79B | |
| +1.41% | +2.60% | +22.40% | +45.37% | 7.09B | |
| -0.91% | +2.53% | +53.18% | -8.37% | 6.99B | |
| +0.81% | +1.14% | +25.69% | +226.08% | 6.53B | |
| +9.12% | +6.89% | -29.64% | +6.47% | 5.4B | |
| Average | +0.60% | +1.76% | +15.88% | +85.61% | 14.21B | |
| Weighted average by Cap. | +0.10% | +1.73% | +23.06% | +83.27% |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-29 | €19.90 | -5.24% | 25 |
| 26-06-26 | €21.00 | +2.94% | 28 |
- Stock Market
- Stocks
- MOLNRIPO Stock
Select your edition
All financial news and data tailored to specific country editions
